InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by KANE MATTHEW R., Chief Executive Officer. Officer active across 1 companies, notably Precision Biosciences INC. Aggregated, 4 filings have been logged. The latest transaction was disclosed on 13 May 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
€71321,514 shares@ €0.03310.0007% mcap50.0% of flow
Common Stock
SEC:0001209191-21-032773·
€71321,514 shares@ €0.03310.0007% mcap25.0% of flow
Common Stock
SEC:0001209191-21-032773:0·
€71321,514 shares@ €0.03310.0007% mcap50.0% of flow
Common Stock
SEC:0001209191-21-031670·
€71321,514 shares@ €0.03310.0007% mcap25.0% of flow
Common Stock
SEC:0001209191-21-031670:0·
4 of 4 declarations
About KANE MATTHEW R.
Matthew R. Kane is the President and CEO of Precision BioSciences Inc. In this role, he oversees the company's operations and leads strategic initiatives. Kane is recognized for his expertise in the biopharmaceutical sector and his commitment to innovation.
